Global Opioid Withdrawal Treatment Market Research Report 2024
Published on: 2024-01-04 | No of Pages : 400 | Industry : Medical
Publisher : MRA | Format : PDF
Global Opioid Withdrawal Treatment Market Research Report 2024
In some cases, usage of opioids causes addiction, and opioid withdrawal syndrome is a life-threatening condition resulting from opioid dependence. These drugs can also cause severe health problems and sometimes even result in overdose and loss of life. Hence this opioid dependence requires treatment, which is known as opioids withdrawal treatment.
According to MRAResearch’s new survey, global Opioid Withdrawal Treatment market is projected to reach US$ 2520 million in 2033, increasing from US$ 1655.7 million in 2022, with the CAGR of 5.7% during the period of 2023 to 2033. Influencing issues, such as economy environments, COVID-19 and Russia-Ukraine War, have led to great market fluctuations in the past few years and are considered comprehensively in the whole Opioid Withdrawal Treatment market research.
Key companies engaged in the Opioid Withdrawal Treatment industry include Merck & Co., Teva Pharmaceutical Industries Ltd, Pfizer Inc., Novartis, Sanofi, Johnson & Johnson Services, Hoffmann-La Roche Ltd and Bayer AG, etc. Among those companies, the top 3 players guaranteed % supply worldwide in 2022.
When refers to consumption region, % value of Opioid Withdrawal Treatment were sold to North America, Europe and Asia Pacific in 2022. Moreover, China, plays a key role in the whole Opioid Withdrawal Treatment market and estimated to attract more attentions from industry insiders and investors.
Report Scope
This report, based on historical analysis (2018-2022) and forecast calculation (2023-2033), aims to help readers to get a comprehensive understanding of global Opioid Withdrawal Treatment market with multiple angles, which provides sufficient supports to readers’ strategy and decision making.
Merck & Co.
Teva Pharmaceutical Industries Ltd
Pfizer Inc.
Novartis
Sanofi
Johnson & Johnson Services
Hoffmann-La Roche Ltd
Bayer AG
Segment by Type
Anti-Inflammatory Drugs
Anti-Nausea Medications
Analgesics
Others
Hospital Pharmacy
Retail Pharmacies
Online Stores
By Region
North America
United States
Canada
Europe
Germany
France
UK
Italy
Russia
Nordic Countries
Rest of Europe
Asia-Pacific
China
Japan
South Korea
Southeast Asia
India
Australia
Rest of Asia
Latin America
Mexico
Brazil
Rest of Latin America
Middle East & Africa
Turkey
Saudi Arabia
UAE
Rest of MEA
The Opioid Withdrawal Treatment report covers below items
Chapter 1Product Basic Information (Definition, Type and Application)
Chapter 2Global market size, regional market size. Market Opportunities and Challenges
Chapter 3Companies’ Competition Patterns
Chapter 4Product Type Analysis
Chapter 5Product Application Analysis
Chapter 6 to 10Country Level Value Analysis
Chapter 11Companies' Outline
Chapter 12Market Conclusions
Chapter 13Research Methodology and Data Source
According to MRAResearch’s new survey, global Opioid Withdrawal Treatment market is projected to reach US$ 2520 million in 2033, increasing from US$ 1655.7 million in 2022, with the CAGR of 5.7% during the period of 2023 to 2033. Influencing issues, such as economy environments, COVID-19 and Russia-Ukraine War, have led to great market fluctuations in the past few years and are considered comprehensively in the whole Opioid Withdrawal Treatment market research.
Key companies engaged in the Opioid Withdrawal Treatment industry include Merck & Co., Teva Pharmaceutical Industries Ltd, Pfizer Inc., Novartis, Sanofi, Johnson & Johnson Services, Hoffmann-La Roche Ltd and Bayer AG, etc. Among those companies, the top 3 players guaranteed % supply worldwide in 2022.
When refers to consumption region, % value of Opioid Withdrawal Treatment were sold to North America, Europe and Asia Pacific in 2022. Moreover, China, plays a key role in the whole Opioid Withdrawal Treatment market and estimated to attract more attentions from industry insiders and investors.
Report Scope
This report, based on historical analysis (2018-2022) and forecast calculation (2023-2033), aims to help readers to get a comprehensive understanding of global Opioid Withdrawal Treatment market with multiple angles, which provides sufficient supports to readers’ strategy and decision making.
By Company
Merck & Co.
Teva Pharmaceutical Industries Ltd
Pfizer Inc.
Novartis
Sanofi
Johnson & Johnson Services
Hoffmann-La Roche Ltd
Bayer AG
Segment by Type
Anti-Inflammatory Drugs
Anti-Nausea Medications
Analgesics
Others
Segment by Application
Hospital Pharmacy
Retail Pharmacies
Online Stores
By Region
North America
United States
Canada
Europe
Germany
France
UK
Italy
Russia
Nordic Countries
Rest of Europe
Asia-Pacific
China
Japan
South Korea
Southeast Asia
India
Australia
Rest of Asia
Latin America
Mexico
Brazil
Rest of Latin America
Middle East & Africa
Turkey
Saudi Arabia
UAE
Rest of MEA
The Opioid Withdrawal Treatment report covers below items
Chapter 1Product Basic Information (Definition, Type and Application)
Chapter 2Global market size, regional market size. Market Opportunities and Challenges
Chapter 3Companies’ Competition Patterns
Chapter 4Product Type Analysis
Chapter 5Product Application Analysis
Chapter 6 to 10Country Level Value Analysis
Chapter 11Companies' Outline
Chapter 12Market Conclusions
Chapter 13Research Methodology and Data Source